- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05706948
High Intensity Interval Training on Cardiopulmonary Parameters With or Without Facemask in Healthy Participants
July 7, 2023 updated by: Riphah International University
Effects of High Intensity Interval Training on Cardiopulmonary Parameters With or Without Facemask in Healthy Participants
To determine the effects of high intensity interval training on cardiovascular function, cardio metabolic markers and cardiorespiratory fitness in healthy individuals with or without facemask
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fedral
-
Islamabad, Fedral, Pakistan, 44000
- Islamabad Medical & Surgical Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Non smoker
- Free of any heart and lung diseases
- Passed Physical Activity Readiness Questionnaire PAR-Q
- To be able to do exercise
Exclusion Criteria:
- Any physical limitation that restrict exercise
- Any neurological illness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High Intensity Interval Training (With Face Mask)
|
High Intensity Interval Training on Treadmill for 4 weeks with Face mask
|
|
Experimental: High Intensity Interval Training (Without Face Mask)
|
High Intensity Interval Training on Treadmill for 4 weeks with out Face mask
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pulse
Time Frame: 4 weeks
|
Changes from the baseline, Pulse will be measured in Beats per minutes with Pulse oximeter.
|
4 weeks
|
|
Oxygen saturation
Time Frame: 4 weeks
|
Changes from the baseline, Oxygen saturation will be measured in Percentages with pulse oximeter
|
4 weeks
|
|
Waist circumference
Time Frame: 4 weeks
|
Waist circumference will be measured for abdominal or central fat mass.
It is measured in cm at the middle distance between the last floating rib and the iliac crest using a retractable ergonomic measuring tape.
Change from the baseline to 4 week will be compared
|
4 weeks
|
|
Modified BORG Scale
Time Frame: 4 weeks
|
The Modified Borg Dyspnea Scale is numerical rating scale ranging from 0 to 10 and is used to measure dyspnea that patient report during sub-maximal exercise and is regularly administered during six-minute walk test.
Changes from the baseline will be measured
|
4 weeks
|
|
Vo2 Max
Time Frame: 4 weeks
|
Changes from the baseline ;The maximum or optimum rate at which the heart, lungs and muscles can effectively use oxygen during exercise, used as a way of measuring a person's individual aerobic capacity.
|
4 weeks
|
|
Body Mas Index
Time Frame: 4 weeks
|
Changes from the baseline, Body Mass Index can be define as statistical index utilizing an individual's height and weight to give an estimation of muscle versus fat in female and male of all ages.
It is determined by taking an individual weight in kilograms, separated by their height in meters squared, or BMI = weight (in kg)/height (in m square).
|
4 weeks
|
|
Hip circumference
Time Frame: 4 weeks
|
Hip measurement is an estimation of the hips, utilizing a measuring tape, for assessment of spatial distance between each relating hipbone with respect to the buttocks.
Hip circumference can be a significant estimation in deciding combined muscle to fat ratio around the waist that might reflect sedentary lifestyle.
|
4 weeks
|
|
Waist to hip ratio
Time Frame: 4 weeks
|
Waist to hip ratio is defined as a ratio of circumference of waist to that of hip.
|
4 weeks
|
|
Forced Expiratory Volume in 1 second (FEV1)
Time Frame: 4 weeks
|
Changes from the Baseline, the digital spirometer is used in clinical setting to analyze Forced Expiratory Volume in 1 second FEV1 in Liters
|
4 weeks
|
|
Forced vital Capacity (FVC)
Time Frame: 4 weeks
|
Changes From the Baseline, the digital spirometer is used in clinical setting to analyze Forced vital Capacity in Liters.
|
4 weeks
|
|
Peak Expiratory Flow
Time Frame: 4 weeks
|
Changes From the Baseline, the digital spirometer is used in clinical setting to analyze Peak Expiratory Flow in Liters.
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Muhammad iqbal Tariq, PhD*, Riphah International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 15, 2023
Primary Completion (Actual)
July 1, 2023
Study Completion (Actual)
July 1, 2023
Study Registration Dates
First Submitted
January 22, 2023
First Submitted That Met QC Criteria
January 30, 2023
First Posted (Actual)
January 31, 2023
Study Record Updates
Last Update Posted (Actual)
July 10, 2023
Last Update Submitted That Met QC Criteria
July 7, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- REC/01370 Muneeba Fatima Tariq
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.